PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01169012
First received: July 22, 2010
Last updated: July 12, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)